透析患者残余肾功能的测量和评估。
Measurement and Estimation of Residual Kidney Function in Patients on Dialysis.
机构信息
Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; and Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA.
Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, MD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; and Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA.
出版信息
Adv Chronic Kidney Dis. 2018 Jan;25(1):93-104. doi: 10.1053/j.ackd.2017.09.001.
Abstract
Residual kidney function (RKF) in patients on dialysis is strongly associated with survival and better quality of life. Assessment of kidney function underlies the management of patients with chronic kidney disease before dialysis initiation. However, methods to assess RKF after dialysis initiation are just now being refined. In this review, we discuss the definition of RKF and methods for measurement and estimation of RKF, highlighting the unique aspects of dialysis that impact these assessments.
摘要
透析患者的残余肾功能（RKF）与生存和生活质量密切相关。在开始透析之前，对慢性肾脏病患者的肾功能进行评估是管理的基础。然而，目前刚刚对透析开始后 RKF 的评估方法进行了改进。在这篇综述中，我们讨论了 RKF 的定义以及 RKF 的测量和估计方法，并强调了影响这些评估的透析的独特方面。
相似文献
1
Measurement and Estimation of Residual Kidney Function in Patients on Dialysis.透析患者残余肾功能的测量和评估。
Adv Chronic Kidney Dis. 2018 Jan;25(1):93-104. doi: 10.1053/j.ackd.2017.09.001.
2
Rationale and Strategies for Preserving Residual Kidney Function in Dialysis Patients.透析患者保留残余肾功能的理由和策略。
Am J Nephrol. 2019;50(6):411-421. doi: 10.1159/000503805. Epub 2019 Oct 18.
3
Residual Kidney Function: Implications in the Era of Personalized Medicine.残余肾功能：个性化医疗时代的意义
Semin Dial. 2017 May;30(3):241-245. doi: 10.1111/sdi.12587. Epub 2017 Mar 6.
4
The importance of residual kidney function for patients on dialysis: a critical review.残余肾功能对透析患者的重要性：一项批判性综述。
Am J Kidney Dis. 2009 Jun;53(6):1068-81. doi: 10.1053/j.ajkd.2009.02.012. Epub 2009 Apr 25.
5
Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?增量透析以保留残余肾功能——开始透析时是否有一种通用的方法？
Semin Dial. 2018 Jul;31(4):343-352. doi: 10.1111/sdi.12701. Epub 2018 May 7.
6
Individualized Hemodialysis Treatment: A Perspective on Residual Kidney Function and Precision Medicine in Nephrology.个体化血液透析治疗：肾脏病学中残余肾功能与精准医学的视角。
Cardiorenal Med. 2019;9(2):69-82. doi: 10.1159/000494808. Epub 2018 Dec 11.
7
Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.新透析患者的递增式血液透析、残余肾功能与死亡风险：一项队列研究
Am J Kidney Dis. 2016 Aug;68(2):256-265. doi: 10.1053/j.ajkd.2016.01.008. Epub 2016 Feb 9.
8
Estimated glomerular filtration rate at dialysis initiation and subsequent decline in residual kidney function among incident hemodialysis patients.起始透析时的估计肾小球滤过率与新进入血液透析患者残余肾功能的后续下降。
Nephrol Dial Transplant. 2020 Oct 1;35(10):1786-1793. doi: 10.1093/ndt/gfaa055.
9
Preservation of residual kidney function in hemodialysis patients: reviving an old concept.维持血液透析患者的残余肾功能：重拾一个古老的概念。
Kidney Int. 2016 Aug;90(2):262-271. doi: 10.1016/j.kint.2016.02.037. Epub 2016 May 12.
10
Preserved residual kidney function after twelve years' hemodialysis.十二年血液透析后保留的残余肾功能。
Ren Fail. 2009;31(8):740-2. doi: 10.3109/08860220903100671.
引用本文的文献
1
Continuous beta-2 microglobulin-based clearance highlights superiority of high-Dose HDF over high-flux HD in predicting outcomes.基于连续β2微球蛋白的清除率突出了高剂量血液透析滤过在预测结果方面优于高通量血液透析。
Sci Rep. 2025 Jul 1;15(1):20421. doi: 10.1038/s41598-025-07497-2.
2
Intradialytic optical assessment of C-mannosyl tryptophan removal using spent dialysate.利用用过的透析液对C-甘露糖基色氨酸清除情况进行透析内光学评估。
Sci Rep. 2025 Jun 12;15(1):20052. doi: 10.1038/s41598-025-01844-z.
3
ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury.美国肾脏病学会关于需要透析的急性肾损伤患者门诊管理的指南。
J Am Soc Nephrol. 2025 May 1;36(5):926-939. doi: 10.1681/ASN.0000000646. Epub 2025 Feb 27.
4
Cystatin C and Kidney Function Recovery in Patients Requiring Continuous KRT for Acute Kidney Injury.急性肾损伤需要持续肾脏替代治疗患者的胱抑素C与肾功能恢复
Clin J Am Soc Nephrol. 2024 Nov 1;19(11):1395-1404. doi: 10.2215/CJN.0000000000000531. Epub 2024 Aug 21.
5
Residual Kidney Function in Hemodialysis: Its Importance and Contribution to Improved Patient Outcomes.血液透析患者的残余肾功能：其重要性及其对改善患者预后的贡献。
Toxins (Basel). 2024 Jun 28;16(7):298. doi: 10.3390/toxins16070298.
6
A practical approach to implementing incremental haemodialysis.实施递增血液透析的实用方法。
J Nephrol. 2024 Sep;37(7):1791-1799. doi: 10.1007/s40620-024-01939-2. Epub 2024 May 19.
7
Redefining the concept of residual renal function with kidney sodium MRI: a pilot study.用肾脏钠 MRI 重新定义残余肾功能的概念：一项初步研究。
Nephrol Dial Transplant. 2024 Oct 30;39(11):1809-1816. doi: 10.1093/ndt/gfae070.
8
Antioxidants for adults with chronic kidney disease.抗氧化剂治疗慢性肾脏病成人患者。
Cochrane Database Syst Rev. 2023 Nov 2;11(11):CD008176. doi: 10.1002/14651858.CD008176.pub3.
9
Recent Advances in Sodium Magnetic Resonance Imaging and Its Future Role in Kidney Disease.钠磁共振成像的最新进展及其在肾脏疾病中的未来作用。
J Clin Med. 2023 Jun 29;12(13):4381. doi: 10.3390/jcm12134381.
10
Trajectories of eGFR after kidney transplantation according to trajectories of eGFR prior to kidney replacement therapies in children with chronic kidney disease.根据慢性肾脏病儿童肾替代治疗前 eGFR 轨迹，分析肾移植后 eGFR 轨迹。
Pediatr Nephrol. 2023 Dec;38(12):4157-4164. doi: 10.1007/s00467-023-06056-z. Epub 2023 Jun 23.
本文引用的文献
1
Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases.重新发现β2微球蛋白作为全谱肾脏疾病生物标志物的价值
Front Med (Lausanne). 2017 Jun 15;4:73. doi: 10.3389/fmed.2017.00073. eCollection 2017.
2
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.老年人低分子量血清蛋白滤过标志物的非肾小球滤过率决定因素：AGES-肾脏研究和MESA-肾脏研究
Am J Kidney Dis. 2017 Sep;70(3):406-414. doi: 10.1053/j.ajkd.2017.03.021. Epub 2017 May 24.
3
β-Trace Protein Assays: A Comparison Between Nephelometric and ELISA Methodologies.β-微球蛋白检测：散射比浊法与酶联免疫吸附测定法的比较
Am J Kidney Dis. 2017 Jun;69(6):866-868. doi: 10.1053/j.ajkd.2017.02.371. Epub 2017 Apr 12.
4
The Interaction of Dialysis Prescription and Residual Kidney Function: Yet Another Layer of Complexity.透析处方与残余肾功能的相互作用：复杂性的又一层面。
Am J Kidney Dis. 2017 Apr;69(4):489-491. doi: 10.1053/j.ajkd.2017.01.001.
5
Incremental Hemodialysis: The University of California Irvine Experience.递增式血液透析：加利福尼亚大学欧文分校的经验
Semin Dial. 2017 May;30(3):262-269. doi: 10.1111/sdi.12591. Epub 2017 Mar 14.
6
Residual Kidney Function: Implications in the Era of Personalized Medicine.残余肾功能：个性化医疗时代的意义
Semin Dial. 2017 May;30(3):241-245. doi: 10.1111/sdi.12587. Epub 2017 Mar 6.
7
β-trace protein is highly removed during haemodialysis with high-flux and super high-flux membranes.使用高通量和超高通量膜进行血液透析时，β-微球蛋白的清除率很高。
BMC Nephrol. 2017 Feb 20;18(1):68. doi: 10.1186/s12882-017-0489-6.
8
Residual renal function: a paradigm shift.残余肾功能：范式转变。
Kidney Int. 2017 Mar;91(3):561-565. doi: 10.1016/j.kint.2016.09.052.
9
Multicenter Evaluation of Cystatin C Measurement after Assay Standardization.胱抑素 C 测定标准化后的多中心评估。
Clin Chem. 2017 Apr;63(4):833-841. doi: 10.1373/clinchem.2016.264325. Epub 2017 Feb 10.
10
Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?临床实践和研究中用于测量肾小球滤过率的碘海醇血浆清除率：综述。第1部分：如何用碘海醇测量肾小球滤过率？
Clin Kidney J. 2016 Oct;9(5):682-99. doi: 10.1093/ckj/sfw070. Epub 2016 Aug 23.
Zotero 插件